As of 2024-12-14, the Relative Valuation of Phathom Pharmaceuticals Inc (PHAT) is (117.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.99 USD, the upside of Phathom Pharmaceuticals Inc based on Relative Valuation is -1573.4%.
The range of the Relative Valuation is (73.97) - (117.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.9x - 23.7x | 22.5x |
| Forward P/E multiples | 14.9x - 25.5x | 24.9x |
| Fair Price | (73.97) - (117.65) | (117.65) |
| Upside | -1026.3% - -1573.4% | -1573.4% |
| Date | P/E |
| 2024-11-29 | -1.79 |
| 2024-11-27 | -1.81 |
| 2024-11-26 | -1.81 |
| 2024-11-25 | -1.83 |
| 2024-11-22 | -1.88 |
| 2024-11-21 | -1.90 |
| 2024-11-20 | -1.76 |
| 2024-11-19 | -1.89 |
| 2024-11-18 | -1.79 |
| 2024-11-15 | -1.77 |
| 2024-11-14 | -1.83 |
| 2024-11-13 | -1.96 |
| 2024-11-12 | -1.92 |
| 2024-11-11 | -2.64 |
| 2024-11-08 | -3.40 |
| 2024-11-07 | -3.73 |
| 2024-11-06 | -3.63 |
| 2024-11-05 | -3.70 |
| 2024-11-04 | -3.82 |
| 2024-11-01 | -3.68 |
| 2024-10-31 | -3.45 |
| 2024-10-30 | -3.51 |
| 2024-10-29 | -3.48 |
| 2024-10-28 | -3.50 |
| 2024-10-25 | -3.23 |
| 2024-10-24 | -3.27 |
| 2024-10-23 | -3.29 |
| 2024-10-22 | -3.34 |
| 2024-10-21 | -3.13 |
| 2024-10-18 | -3.24 |
| 2024-10-17 | -3.27 |
| 2024-10-16 | -3.32 |
| 2024-10-15 | -3.15 |
| 2024-10-14 | -3.08 |
| 2024-10-11 | -3.04 |
| 2024-10-10 | -3.16 |
| 2024-10-09 | -3.17 |
| 2024-10-08 | -3.32 |
| 2024-10-07 | -3.24 |
| 2024-10-04 | -3.47 |
| 2024-10-03 | -3.66 |
| 2024-10-02 | -3.38 |
| 2024-10-01 | -3.42 |
| 2024-09-30 | -3.64 |
| 2024-09-27 | -3.53 |
| 2024-09-26 | -3.59 |
| 2024-09-25 | -3.56 |
| 2024-09-24 | -3.47 |
| 2024-09-23 | -3.58 |
| 2024-09-20 | -3.71 |